Local Minocycline to Reduce Future Inflammation and Bone Loss in Periodontal Maintenance Patients

Sponsor
University of Nebraska (Other)
Overall Status
Completed
CT.gov ID
NCT01647282
Collaborator
(none)
60
2
2
39
30
0.8

Study Details

Study Description

Brief Summary

The purpose of this study is to determine the effect of local application of minocycline microspheres on the periodontal inflammation and bone loss prevention in patients diagnosed with moderate-severe chronic periodontitis within a periodontal maintenance program.

Condition or Disease Intervention/Treatment Phase
  • Drug: locally-applied minocycline HCl (1 mg)
  • Procedure: scaling and root planing (Sc/RP)
Phase 4

Detailed Description

The over-arching goal of this application is to initiate a program to involve undergraduate dental students and their patients in clinical research to evaluate the efficacy of dental therapy. Specifically, the purpose of this study is to determine the effect of local application of minocycline microspheres on the periodontal inflammation and bone loss prevention in patients diagnosed with moderate-severe chronic periodontitis on periodontal maintenance in the undergraduate clinic. Few studies evaluating locally-applied minocycline during periodontal maintenance therapy have been reported even though the drug is commonly used in this protocol. A 6-month treatment study by Meinberg et al. (2002), demonstrated that in moderate-to-advanced chronic periodontitis patients, scaling and root planing with subgingival minocycline resulted in improved pocket depths and less frequent bone height loss over one year than conventional periodontal maintenance. The prevention of bone loss and inflammation is key to maintaining teeth in function and comfort for the patient's lifetime. Patients from the UNMC College of Dentistry (and eventually Creighton University School of Dentistry) undergraduate periodontal clinic, who are already enrolled in periodontal maintenance therapy, will be recruited to participate in this study. The selected patients will continue their periodontal maintenance care but will be placed into either the test group (receiving minocycline in a periodontally inflamed pocket along with subgingival mechanical debridement) or the control group (receiving subgingival mechanical debridement alone). Radiographs will be taken at baseline and at the study's completion (24 months) to obtain bone loss data, and periodontal measurements and gingival crevicular fluid (GCF) will be used to monitor markers of inflammation and bone resorption. The hypothesis to be tested in this clinical trial is that the use of minocycline at baseline and 6 month intervals in conjunction with subgingival mechanical debridement will reduce interproximal bone height loss and periodontal inflammation more than mechanical debridement alone.

Study Design

Study Type:
Interventional
Actual Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Investigator)
Primary Purpose:
Treatment
Official Title:
Local Minocycline to Reduce Future Inflammation and Bone Loss in Periodontal Maintenance Patients
Study Start Date :
Sep 1, 2012
Actual Primary Completion Date :
Dec 1, 2015
Actual Study Completion Date :
Dec 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Experimental: Sc/RP with minocycline micropheres

Sc/RP is the subgingival mechanical removal of calculus and diseased cementum from the tooth root. Local application of minocycline microspheres will be done after scaling and root planing (Sc/RP) has been completed

Drug: locally-applied minocycline HCl (1 mg)
Other Names:
  • Arestin (minocycline microspheres) 1 mg
  • Procedure: scaling and root planing (Sc/RP)

    Active Comparator: Sc/RP alone

    Sc/RP is the subgingival mechanical removal of calculus and diseased cementum from the tooth root

    Procedure: scaling and root planing (Sc/RP)

    Outcome Measures

    Primary Outcome Measures

    1. Change in Interproximal Bone Height Loss, Probing Depth and Clinical Attachment Level Over 24 Months [24 months]

      Changes in interproximal bone height loss were measured over the course of 24 months in two groups; patients receiving scaling and root planing alone in a deep periodontal pocket and those receiving scaling and root planing as well as minocycline microspheres in a deep periodontal pocket. These changes in interproximal bone height loss (mm) were determined via bitewing radiographs taken at baseline and 24 months and measured as distance from the cemento-enamel junction to the alveolar bone. Changes in probing depth (mm) were measured from the gingival margin to the depth of periodontal pocket. Changes in clinical attachment level (mm) were determined by adding the measure of gingival recession and the probing depth.

    Secondary Outcome Measures

    1. Inflammatory Biomarkers Found in Gingival Crevicular Fluid: IL-1. [24 months]

      The gingival crevicular fluid is analyzed biochemically and the levels of inflammatory biomarkers can be determined. Specific biomarkers are inherent in periodontal disease and have been shown to be indicative of periodontal breakdown within a pocket. In this study, the biomarker, IL-1 were assessed for their presence and quantity within the GCF samples taken from the experimental periodontal pockets at baseline and 24 months.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    40 Years to 85 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • diagnosis of moderate-severe chronic periodontitis

    • attending regular periodontal maintenance visits at UNMC COD

    • one quadrant with at least one > 5 mm interproximal pocket and 3 posterior teeth

    Exclusion Criteria:
    • systemic diseases which impact periodontal inflammation and bone turnover

    • drugs which significantly impact periodontal inflammation and bone turnover

    • surgical periodontal therapy within the last year

    • pregnant or breast-feeding females

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Nebraska College of Dentistry Lincoln Nebraska United States 68583
    2 Creighton University School of Dentistry Omaha Nebraska United States

    Sponsors and Collaborators

    • University of Nebraska

    Investigators

    • Principal Investigator: Amy C Killeen, DDS, MS, UNMC College of Dentistry

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Amy C. Killeen, DDS, MS, Assistant Professor, University of Nebraska
    ClinicalTrials.gov Identifier:
    NCT01647282
    Other Study ID Numbers:
    • 314-12-FB
    First Posted:
    Jul 23, 2012
    Last Update Posted:
    Dec 13, 2017
    Last Verified:
    Nov 1, 2017

    Study Results

    Participant Flow

    Recruitment Details
    Pre-assignment Detail
    Arm/Group Title Sc/RP With Minocycline Micropheres Sc/RP Alone
    Arm/Group Description Sc/RP is the subgingival mechanical removal of calculus and diseased cementum from the tooth root. Local application of minocycline microspheres will be done after scaling and root planing (Sc/RP) has been completed locally-applied minocycline HCl (1 mg) scaling and root planing (Sc/RP) Sc/RP is the subgingival mechanical removal of calculus and diseased cementum from the tooth root scaling and root planing (Sc/RP)
    Period Title: Overall Study
    STARTED 30 30
    COMPLETED 23 25
    NOT COMPLETED 7 5

    Baseline Characteristics

    Arm/Group Title Sc/RP With Minocycline Micropheres Sc/RP Alone Total
    Arm/Group Description Sc/RP is the subgingival mechanical removal of calculus and diseased cementum from the tooth root. Local application of minocycline microspheres will be done after scaling and root planing (Sc/RP) has been completed locally-applied minocycline HCl (1 mg) scaling and root planing (Sc/RP) Sc/RP is the subgingival mechanical removal of calculus and diseased cementum from the tooth root scaling and root planing (Sc/RP) Total of all reporting groups
    Overall Participants 23 25 48
    Age (Count of Participants)
    <=18 years
    0
    0%
    0
    0%
    0
    0%
    Between 18 and 65 years
    23
    100%
    25
    100%
    48
    100%
    >=65 years
    0
    0%
    0
    0%
    0
    0%
    Age (years) [Mean (Standard Deviation) ]
    Mean (Standard Deviation) [years]
    67.3
    (10.5)
    66.8
    (12.1)
    67.1
    (11.0)
    Sex: Female, Male (Count of Participants)
    Female
    9
    39.1%
    9
    36%
    18
    37.5%
    Male
    14
    60.9%
    16
    64%
    30
    62.5%
    Race and Ethnicity Not Collected (Count of Participants)
    Count of Participants [Participants]
    0
    0%
    Region of Enrollment (participants) [Number]
    United States
    23
    100%
    25
    100%
    48
    100%

    Outcome Measures

    1. Primary Outcome
    Title Change in Interproximal Bone Height Loss, Probing Depth and Clinical Attachment Level Over 24 Months
    Description Changes in interproximal bone height loss were measured over the course of 24 months in two groups; patients receiving scaling and root planing alone in a deep periodontal pocket and those receiving scaling and root planing as well as minocycline microspheres in a deep periodontal pocket. These changes in interproximal bone height loss (mm) were determined via bitewing radiographs taken at baseline and 24 months and measured as distance from the cemento-enamel junction to the alveolar bone. Changes in probing depth (mm) were measured from the gingival margin to the depth of periodontal pocket. Changes in clinical attachment level (mm) were determined by adding the measure of gingival recession and the probing depth.
    Time Frame 24 months

    Outcome Measure Data

    Analysis Population Description
    Patients included had moderate-severe chronic periodontitis with a >/= 5 mm interproximal, posterior pocket that bled upon probing. Participating patients had a history of regular periodontal maintenance therapy and no systemic disease (rheumatoid arthritis, osteoporosis, tetracycline allergy) or medications with bone-turnover significance.
    Arm/Group Title Sc/RP With Minocycline Micropheres Sc/RP Alone
    Arm/Group Description Sc/RP is the subgingival mechanical removal of calculus and diseased cementum from the tooth root. Local application of minocycline microspheres will be done after scaling and root planing (Sc/RP) has been completed locally-applied minocycline HCl (1 mg) scaling and root planing (Sc/RP) Sc/RP is the subgingival mechanical removal of calculus and diseased cementum from the tooth root scaling and root planing (Sc/RP)
    Measure Participants 23 25
    Interproximal Bone Loss Baseline
    3.78
    (1.43)
    3.87
    (1.11)
    Interproximal Bone Loss 24 Months
    3.57
    (1.45)
    3.8
    (1.13)
    Probing Depth - Baseline
    5.29
    (0.62)
    5.48
    (0.75)
    Probing Depth - 24 Months
    4.14
    (0.89)
    3.96
    (0.73)
    Clinical Attachment Level - Baseline
    5.42
    (0.65)
    4.36
    (1.05)
    Clinical Attachment Level - 24 Months
    5.81
    (0.92)
    4.24
    (0.66)
    2. Secondary Outcome
    Title Inflammatory Biomarkers Found in Gingival Crevicular Fluid: IL-1.
    Description The gingival crevicular fluid is analyzed biochemically and the levels of inflammatory biomarkers can be determined. Specific biomarkers are inherent in periodontal disease and have been shown to be indicative of periodontal breakdown within a pocket. In this study, the biomarker, IL-1 were assessed for their presence and quantity within the GCF samples taken from the experimental periodontal pockets at baseline and 24 months.
    Time Frame 24 months

    Outcome Measure Data

    Analysis Population Description
    Patients included had moderate-severe chronic periodontitis with a >/= 5 mm interproximal, posterior pocket that bled upon probing. Participating patients had a history of regular periodontal maintenance therapy and no systemic disease (rheumatoid arthritis, osteoporosis, tetracycline allergy) or medications with bone-turnover significance.
    Arm/Group Title Sc/RP With Minocycline Micropheres Sc/RP Alone
    Arm/Group Description Sc/RP is the subgingival mechanical removal of calculus and diseased cementum from the tooth root. Local application of minocycline microspheres will be done after scaling and root planing (Sc/RP) has been completed locally-applied minocycline HCl (1 mg) scaling and root planing (Sc/RP) Sc/RP is the subgingival mechanical removal of calculus and diseased cementum from the tooth root scaling and root planing (Sc/RP)
    Measure Participants 23 25
    Gingival Crevicular Fluid - Baseline
    9.29
    (2.12)
    9.95
    (1.98)
    Gingival Crevicular Fluid - 24 months
    10.30
    (2.21)
    10.53
    (2.16)

    Adverse Events

    Time Frame
    Adverse Event Reporting Description
    Arm/Group Title Sc/RP With Minocycline Micropheres Sc/RP Alone
    Arm/Group Description Sc/RP is the subgingival mechanical removal of calculus and diseased cementum from the tooth root. Local application of minocycline microspheres will be done after scaling and root planing (Sc/RP) has been completed locally-applied minocycline HCl (1 mg) scaling and root planing (Sc/RP) Sc/RP is the subgingival mechanical removal of calculus and diseased cementum from the tooth root scaling and root planing (Sc/RP)
    All Cause Mortality
    Sc/RP With Minocycline Micropheres Sc/RP Alone
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 0/23 (0%) 0/25 (0%)
    Serious Adverse Events
    Sc/RP With Minocycline Micropheres Sc/RP Alone
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 0/23 (0%) 0/25 (0%)
    Other (Not Including Serious) Adverse Events
    Sc/RP With Minocycline Micropheres Sc/RP Alone
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 0/23 (0%) 0/25 (0%)

    Limitations/Caveats

    [Not Specified]

    More Information

    Certain Agreements

    All Principal Investigators ARE employed by the organization sponsoring the study.

    There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

    Results Point of Contact

    Name/Title Dr. Amy C. Killeen
    Organization UNMC College of Dentistry
    Phone 402-202-7848
    Email akilleen@unmc.edu
    Responsible Party:
    Amy C. Killeen, DDS, MS, Assistant Professor, University of Nebraska
    ClinicalTrials.gov Identifier:
    NCT01647282
    Other Study ID Numbers:
    • 314-12-FB
    First Posted:
    Jul 23, 2012
    Last Update Posted:
    Dec 13, 2017
    Last Verified:
    Nov 1, 2017